Promising results from clinical trial of a probiotic
Date
Research news
Date
Results from a study of a technique known as focused ultrasound have shown a benefit for people with Parkinson’s with movement problems, for up to a year after treatment.
Date
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.
Date
Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson’s symptoms.
Date
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson’s.
Date
A Lord’s inquiry supported by Parkinson’s UK has recommended the UK government urgently prioritises funding and support for clinical research.
Date
Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson’s.
Date
Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.
Date
Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson’s.
Date
Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
Date
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.